<prompt> Answer this question truthfullyWhat are the future or experimental treatments for Parotitis?  <response>: <reason> Aprotinin, a kallikrein inhibitor, is currently being investigated for treatment of chronic parotitis symptoms. Kallikrein release in the parotid gland is associated with the inflammatory edema process. Aprotinin was administered to 7 recurrent parotitis patients, with the following results observed: Pain relieved 12 hours after administration Parotid gland function returned to normal 48 hours after administration Parotid gland swelling resolved after 7 days. More research is warranted on the efficacy of kallikrein inhibition. 